The DOI matches its Crossref record; 47 of the 48 references it cites were found in a registry or an index.
Interleukin-1 Receptor Blockade Is Associated With Reduced Mortality in Sepsis Patients With Features of Macrophage Activation Syndrome: Reanalysis of a Prior Phase III Trial*
Open accessAbstract
OBJECTIVE: To determine the efficacy of anakinra (recombinant interleukin-1 receptor antagonist) in improving 28-day survival in sepsis patients with features of macrophage activation syndrome. Despite equivocal results in sepsis trials, anakinra is effective in treating macrophage activation syndrome, a similar entity with fever, disseminated intravascular coagulation, hepatobiliary dysfunction, cytopenias, and hyperferritinemia. Hence, sepsis patients with macrophage activation syndrome features may benefit from interleukin-1 receptor blockade. DESIGN: Reanalysis of deidentified data from the phase III randomized interleukin-1 receptor antagonist trial in severe sepsis. SETTING: Multicenter study recruiting through 91 centers from 11 countries in Europe and North America. PATIENTS: Sepsis patients with multiorgan dysfunction syndrome and/or shock (original study) were regrouped based on the presence or the absence of concurrent hepatobiliary dysfunction and disseminated intravascular coagulation as features of macrophage activation syndrome. The non-hepatobiliary dysfunction/disseminated intravascular coagulation group included patients with only hepatobiliary dysfunction, only disseminated intravascular coagulation, or neither. INTERVENTION: Treatment with anakinra or placebo. MEASUREMENTS AND MAIN RESULTS: Main outcome was 28-day mortality. Descriptive and comparative statistics were performed. Data were available for 763 adults from the original study cohort, randomized to receive either anakinra or placebo. Concurrent hepatobiliary dysfunction/disseminated intravascular coagulation was noted in 43 patients (5.6% of total; 18-75 years old; 47% women). The 28-day survival was similar in both anakinra and placebo-treated non-hepatobiliary dysfunction/disseminated intravascular coagulation patients (71.4% vs 70.8%; p = 0.88). Treatment with anakinra was associated with significant improvement in the 28-day survival rate in hepatobiliary dysfunction/disseminated intravascular coagulation patients (65.4% anakinra vs 35.3% placebo), with hazard ratio for death 0.28 (0.11-0.71; p = 0.0071) for the treatment group in Cox regression. CONCLUSIONS: In this subgroup analysis, interleukin-1 receptor blockade was associated with significant improvement in survival of patients with sepsis and concurrent hepatobiliary dysfunction/disseminated intravascular coagulation. A prospective randomized trial using features of macrophage activation syndrome for mortality risk stratification should be undertaken to confirm the role of interleukin-1 blockage.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“For example, reanalysis of a negative trial of interleukin-1β blockade in patients with sepsis identified a subgroup of patients with elevated ferritin levels who seemed to benefit from the treatment.63”
From Cytokine storm (2020) · cites this paper as [63]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference
Levy, M. M., Fink, M. P., Marshall, J. C., Abraham, E. H., Angus, D. C., Cook, D., Cohen, J., Opal, S. M., Vincent, J., & Ramsay, G. (2003) · Critical Care Medicine · doi:10.1097/01.ccm.0000050454.01978.3b · Cited by 5,976
Self-citationThe Pathophysiology and Treatment of Sepsis
Hotchkiss, R. S., & Karl, I. E. (2003) · New England Journal of Medicine · doi:10.1056/nejmra021333 · Cited by 4,132
An Expanded Definition of the Adult Respiratory Distress Syndrome
Murray, J. F., Matthay, M. A., Luce, J. M., & Flick, M. R. (1988) · American Review of Respiratory Disease · doi:10.1164/ajrccm/138.3.720 · Cited by 2,641
Interleukin-1 in the pathogenesis and treatment of inflammatory diseases
Dinarello, C. A. (2011) · Blood · doi:10.1182/blood-2010-07-273417 · Cited by 2,248
Self-citationTreating inflammation by blocking interleukin-1 in a broad spectrum of diseases
Dinarello, C. A., Simon, A., & van der Meer, J. W. M. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3800 · Cited by 1,810
Self-citationFardet, L., Galicier, L., Lambotte, O., Marzac, C., Aumont, C., Chahwan, D., Coppo, P., & Hejblum, G. (2014) · Arthritis & Rheumatology · doi:10.1002/art.38690 · Cited by 1,508
Interleukin-1 and the Pathogenesis of the Acute-Phase Response
Epstein, F. H., & Dinarello, C. A. (1984) · New England Journal of Medicine · doi:10.1056/nejm198411293112205 · Cited by 1,151
Self-citationConfirmatory interleukin-1 receptor antagonist trial in severe sepsis
Opal, S. M., Fisher, C. J., Dhainaut, J.-F., Vincent, J., Brase, R., Lowry, S. F., SADOFF, J. C., Slotman, G. J., Levy, H. A., BALK, R. A., et al. (1997) · Critical Care Medicine · doi:10.1097/00003246-199707000-00010 · Cited by 882
Self-citationHighly elevated ferritin levels and the diagnosis of hemophagocytic lymphohistiocytosis
Allen, C. E., Yu, X., Kozinetz, C. A., & McClain, K. L. (2007) · Pediatric Blood & Cancer · doi:10.1002/pbc.21423 · Cited by 637
Research works printed but not linked: 4
- Emmenegger, 2005, Swiss Med Wkly, 135, 299
- Behrens, 2007, J Rheumatol, 34, 1133
- Behrens, 2006, J Rheumatol, 33, 2081
- Marti-Carvajal, 2012, Cochrane Database Syst Rev, 12, CD004388
Cited by
Sorted by citations
Items 801–871 of 871
The role of cytokine response in influenza virus pathogenesis in humans
Gouri, V., Singh, S. R., Khan, A., Sharma, A., & Samant, M. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-15283-2.00013-0
Research Progress on Diagnosis and Treatment of Hemophagocytic Syndrome
丁, 永. (2025) · Advances in Clinical Medicine · doi:10.12677/acm.2025.1541251
Endothelial Control of the Inflammatory Process
Adam, A. P. (2025) · Springer eBooks · doi:10.1007/978-3-031-55254-0_9-1
Successful Treatment of Severe Purpura Fulminans With Anakinra
Zulian, F., Spiezia, L., Amabile, A., Tirelli, F., & Meneghel, A. (2025) · Pediatric Dermatology · doi:10.1111/pde.70034
Yan, A. P., Ocak, S., Yi, M., Wolochacz, A., Mehrdadi, I., Naqvi, A., Gupta, S., & Sung, L. (2025) · doi:10.2196/preprints.87347
Cargill, M., Arcilla, C. K., Kaeley, G. S., Thway, M., Alkhasawneh, A., Makary, R., & Badar, I. (2025) · Cureus · doi:10.7759/cureus.98078
Kooistra, E. J., Waalders, N. J. B., Grondman, I., Janssen, N. A. F., de Nooijer, A., Netea, M. G., van de Veerdonk, F. L., Ewalds, E., van der Hoeven, J. G., Kox, M., et al. (2020) · Figshare · doi:10.6084/m9.figshare.13364505
Karakike, E., Scicluna, B. P., Roumpoutsou, M., Mitrou, I., Karampela, N., Karageorgos, A., Psaroulis, K., Massa, E., Pitsoulis, A., Chaloulis, P., et al. (2022) · Figshare · doi:10.6084/m9.figshare.20098564
Qin, Y., Kernan, K. F., Fan, Z., Park, H.-J., Kim, S., Canna, S. W., Kellum, J. A., Berg, R. A., WESSEL, D. L., Pollack, M. M., et al. (2022) · Figshare · doi:10.6084/m9.figshare.19728457
Self-citationAdditional file 6 of Whole blood transcriptomics identifies subclasses of pediatric septic shock
Yang, J. O., Zinter, M. S., Pellegrini, M. A., Wong, M. Y., Gala, K. P., Markovic, D., Nadel, B. B., Peng, K., Do, N., Mangul, S., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26651379
Additional file 5 of Whole blood transcriptomics identifies subclasses of pediatric septic shock
Yang, J. O., Zinter, M. S., Pellegrini, M. A., Wong, M. Y., Gala, K. P., Markovic, D., Nadel, B. B., Peng, K., Do, N., Mangul, S., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26651376
Kooistra, E. J., Waalders, N. J. B., Grondman, I., Janssen, N. A. F., de Nooijer, A., Netea, M. G., van de Veerdonk, F. L., Ewalds, E., van der Hoeven, J. G., Kox, M., et al. (2020) · Figshare · doi:10.6084/m9.figshare.13364517
Kooistra, E. J., Waalders, N. J. B., Grondman, I., Janssen, N. A. F., de Nooijer, A., Netea, M. G., van de Veerdonk, F. L., Ewalds, E., van der Hoeven, J. G., Kox, M., et al. (2020) · Figshare · doi:10.6084/m9.figshare.13364511
Kooistra, E. J., Waalders, N. J. B., Grondman, I., Janssen, N. A. F., de Nooijer, A., Netea, M. G., van de Veerdonk, F. L., Ewalds, E., van der Hoeven, J. G., Kox, M., et al. (2020) · Figshare · doi:10.6084/m9.figshare.13364514
Fan, Z., Kernan, K. F., Qin, Y., Canna, S., Berg, R. A., WESSEL, D. L., Pollack, M. M., Meert, K. L., Hall, M., Newth, C., et al. (2023) · Figshare · doi:10.6084/m9.figshare.24098190
Self-citationAdditional file 4 of Whole blood transcriptomics identifies subclasses of pediatric septic shock
Yang, J. O., Zinter, M. S., Pellegrini, M. A., Wong, M. Y., Gala, K. P., Markovic, D., Nadel, B. B., Peng, K., Do, N., Mangul, S., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26651373
Additional file 2 of Whole blood transcriptomics identifies subclasses of pediatric septic shock
Yang, J. O., Zinter, M. S., Pellegrini, M. A., Wong, M. Y., Gala, K. P., Markovic, D., Nadel, B. B., Peng, K., Do, N., Mangul, S., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26651367
Kooistra, E. J., Waalders, N. J. B., Grondman, I., Janssen, N. A. F., de Nooijer, A., Netea, M. G., van de Veerdonk, F. L., Ewalds, E., van der Hoeven, J. G., Kox, M., et al. (2020) · Figshare · doi:10.6084/m9.figshare.13364520
Kooistra, E. J., Waalders, N. J. B., Grondman, I., Janssen, N. A. F., de Nooijer, A., Netea, M. G., van de Veerdonk, F. L., Ewalds, E., van der Hoeven, J. G., Kox, M., et al. (2020) · Figshare · doi:10.6084/m9.figshare.13364493
Karakike, E., Scicluna, B. P., Roumpoutsou, M., Mitrou, I., Karampela, N., Karageorgos, A., Psaroulis, K., Massa, E., Pitsoulis, A., Chaloulis, P., et al. (2022) · Figshare · doi:10.6084/m9.figshare.20098561
Additional file 1 of Whole blood transcriptomics identifies subclasses of pediatric septic shock
Yang, J. O., Zinter, M. S., Pellegrini, M. A., Wong, M. Y., Gala, K. P., Markovic, D., Nadel, B. B., Peng, K., Do, N., Mangul, S., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26651364
Additional file 1 of COVID-19 multidisciplinary high dependency unit: the Milan model
Aliberti, S., Amati, F., Pappalettera, M., Di Pasquale, M., D’Adda, A., Mantero, M., Gramegna, A., Simonetta, E., Oneta, A. M., Privitera, E., et al. (2020) · Figshare · doi:10.6084/m9.figshare.13076502
Additional file 1 of Towards personalized medicine: a scoping review of immunotherapy in sepsis
Slim, M. A., van Mourik, N., Bakkerus, L., Fuller, K., Acharya, L. S., Giannidis, T., Dionne, J. C., Oczkowski, S. J. W., Netea, M. G., Pickkers, P., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26726717
Additional file 3 of Whole blood transcriptomics identifies subclasses of pediatric septic shock
Yang, J. O., Zinter, M. S., Pellegrini, M. A., Wong, M. Y., Gala, K. P., Markovic, D., Nadel, B. B., Peng, K., Do, N., Mangul, S., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26651370
Präzisionsimmuntherapie verbessert die Organdysfunktion bei Sepsis
Wild, L. C., & Bode, C. (2026) · Die Anaesthesiologie · doi:10.1007/s00101-026-01644-8
Temporal variation in haemophagocytic lymphohistiocytosis mortality
Tornero-Romero, F., Olmo, L. C.-D., Morante‐Ruiz, M., & Fernando, L.-E. (2026) · The Lancet Rheumatology · doi:10.1016/s2665-9913(26)00008-1
COVID-19 Diagnostic Tests, Vaccines and Medicines in Its Treatment; Current status
Salmanoglu, D. S., Çalışkan, E. E., Meliz, S. O. F. U., Yiğit, U., & Uyanıkgil, E. Ö. Ç. (2021) · DergiPark (Istanbul University)
Sathyanarayana, P. K. K., Mathew, K., Chacko, S., Dilhani, N., & Ilyas, M. (2026) · Cureus · doi:10.7759/cureus.103688
Zidan, A. A., Gad, A. Y. S., Zakaria, N. H., El‐Hariri, H. M., Elsharnouby, N. M., Helmy, M. W., & El‐Setouhy, M. (2026) · Scientific Reports · doi:10.1038/s41598-026-35292-0
Recognizing and Managing Hemophagocytic Lymphohistiocytosis in Adults in the Intensive Care Unit
Shakoory, B., Sereti, I., & Rocco, J. M. (2026) · Critical Care Clinics · doi:10.1016/j.ccc.2026.01.001
Self-citationOcak, S., Yi, M., Wolochacz, A., Mehrdadi, I., Naqvi, A., Gupta, S., Sung, L., & Yan, A. P. (2026) · JMIR Cancer · doi:10.2196/87347
Rôle de l'alarmine IL-33 dans un modèle murin d'ischémie-reperfusion hépatique
Barbier, L. A. (2019) · theses.fr (ABES) · doi:10.70675/10b2c935z2b33z48aaz8ca4z3e15af708fec
Rôle du TNFR2 exprimé par les lymphocytes T régulateurs au cours de l'immunodépression post septique
Gaborit, B. (2019) · theses.fr (ABES) · doi:10.70675/fc216760z171az42f4zade0z7695e77ea077
Crausaz, M. (2022) · theses.fr (ABES) · doi:10.70675/d0a5defazaeb0z46a2zb177z225779634e8f
Vermeersch, V. (2023) · theses.fr (ABES) · doi:10.70675/208ba22bz2ec2z47d3z9889z4157016e475d
Beyond antimicrobials: a host-directed precision pharmacotherapy framework for septic shock
Cheng, X.-Z., Li, J., An, P., Han, B., Li, L.-K., Ma, K.-L., & Zhang, H. (2026) · Frontiers in Medicine · doi:10.3389/fmed.2026.1811347
How I Treat: Haploinsufficiency of A20
Li, J. C., Zhou, J. Y., Tumba, M. C., He, T., Gedik, K. C., & Schwartz, D. M. (2026) · Journal of Human Immunity · doi:10.70962/jhi.20250138
Belfiore, J., Taddei, R., & Suardi, L. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1775585
Ruiz‐Rodríguez, J. C., Chiscano‐Camón, L., Ruiz‐Sanmartín, A., Maldonado, C., Nicolás-Morales, P., Ramírez, C., Ferrer, R., González‐López, J. J., Larrosa, N., & Ferrer, R. (2026) · Blood Purification · doi:10.1159/000552315
Thomas, S. S., Krishnakripa, K., Abhinand, K., Menon, A. M., Ranjith, G., Sony, S. M., Babu, P., Kumar, G. B., Nair, B. G., Arun, K. B., et al. (2026) · Antibiotics · doi:10.3390/antibiotics15050505 · Cited by 1
Amikishiyev, S., Deniz, R., Günver, M. G., Aghamuradov, S., Koca, N., İnce, B., Bektaş, M., Yilmaz, A., Cantürk, Y., Durak, G., et al. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1722572
Hemophagocytic lymphohistiocytosis in critically ill patients: A guide for clinicians
Nedel, W. L. (2026) · World Journal of Critical Care Medicine · doi:10.5492/wjccm.120840
Matni, M. Y. A., Belvitch, P. G., Dudek, S. M., & Letsiou, E. (2026) · Comprehensive physiology · doi:10.1002/cph4.70179
Lee, J., Ko, J., Nam, H., Choi, J., Baek, J. Y., Nam, M., Chung, C. R., Yang, J. H., Suh, G. Y., & Ko, R. (2026) · Diagnostics · doi:10.3390/diagnostics16121814
Global biomarkers trends in sepsis research: a bibliometric analysis from 2005–2025
Zhang, N., He, J., Wang, N., & Ye, G. (2026) · Critical Public Health · doi:10.1080/09581596.2026.2680352
Chiscano‐Camón, L., Ruiz‐Rodríguez, J. C., Ruiz‐Sanmartín, A., Nicolás-Morales, P., Hernández-González, M., & Ferrer, R. (2026) · Journal of Intensive Care · doi:10.1186/s40560-026-00898-z
Yang, S., Jin, L., Liu, L. L., Wang, L., & Hou, Z. (2026) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2026.1874595
Pharmakologische Immunmodulation bei Sepsis
Bode, C. (2026) · Medizinische Klinik - Intensivmedizin und Notfallmedizin · doi:10.1007/s00063-026-01481-y
Martín‐Loeches, I., Restrepo, M. I., & Torres, A. (2026) · Current Opinion in Critical Care · doi:10.1097/mcc.0000000000001410
Combination therapy for fungal diseases: the role of immunotherapy in the present and the future
Seldeslachts, L., Feys, S., van de Veerdonk, F. L., & Wauters, J. (2026) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0000000000001220 · Cited by 1
Beneficial effects of PMX-DHP on vasopressor-resistant invasive meningococcal disease: a case report
Hattori, Y., Chiba, N., Ihara, S., Sato, J., Nakagawa, K., Saito, T., & Kinoshita, K. (2026) · Annals of Medicine and Surgery · doi:10.1097/ms9.0000000000005384
Ansari, S., Bono, K. R., Zhai, M., Subash, A., Shah, A. S., & Kra, J. (2026) · eJHaem · doi:10.1002/jha2.70360
When to initiate immunomodulatory therapy in sepsis
Wen, Y., & Huang, D. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1898450 · Cited by 1
Blade, R., Lecher, S. P., Umstead, T. M., Chroneos, Z. C., Riccio-Baum, C., Allie, S. R., Hahn, T. J., McKeone, D. J., Ericson, J. E., DeMartini, T. K. M., et al. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1904924
From immune heterogeneity to precision medicine in sepsis
Jin, X., Yang, J., Yang, S., & Zhang, Z. (2026) · Journal of Translational Genetics and Genomics · doi:10.20517/jtgg.2026.64
Cytokine-associated ROS and Ca2+ dysregulation in severe inflammatory cardiomyopathy
Suwalski, P., Golpour, A., Weiner, J. M., Musigk, N., Balzer, F., Giesa, N., Amr, A., Żyła, J., Ganz, P., Saleem, H. N., et al. (2026) · Cardiovascular Research · doi:10.1093/cvr/cvag099
Yadav, I., Jha, S. K., Singh, S., Mandal, D. K., & Jha, S. (2026) · Clinical Case Reports · doi:10.1002/ccr3.73434
Bipolar immune dynamics in sepsis: An updated perspective oscillating immunodynamics in sepsis
Su, L., Zhao, G., Rui, X., Wang, L., Scimeca, G., Zhou, L., Zhang, J., Sha, H., Chen, Y., Xi, S., et al. (2026) · Chinese Medical Journal BioMed · doi:10.65457/cmjbm-2026-0007
Reddi, B. A. J. (2026) · Springer eBooks · doi:10.1007/978-3-032-31459-8_2
Septic shock in the era of precision medicine: rethinking fluids, vasopressors, and immunomodulation
Du, J., Feng, H., Dong, S., Yang, C., Al-Danakh, A., & Zhou, S. (2026) · Frontiers in Medicine · doi:10.3389/fmed.2026.1909143
Plasma Exchange for Hantavirus Pulmonary Syndrome: A Mechanistic Case for an Untested Intervention
Nadim, M. K., Mirzabeigi, Y., & Akgun, Y. (2026) · Journal of Clinical Apheresis · doi:10.1002/jca.70187
Boyle, A. J., Ryan, E., Berry, L. R., Berry, S. M., Derde, L. P. G., Lawler, P. R., Lorenzi, E., O’Kane, C. M., Shankar‐Hari, M., van de Veerdonk, F. L., et al. (2026) · Critical Care · doi:10.1186/s13054-026-06311-3
Taming Macrophage Inflammasomes at the Sepsis—Lung Injury Interface: Lessons from Bats
Chen, S., 罗家镏, Zhang, P., Gu, S., Shen, Y., Lin, Z., Wu, Y., Zhang, C., & Tang, Z. (2026) · Biomedicines · doi:10.3390/biomedicines14102325
У., А. Т., Махмудова, З. Т., & Холбоева, Г. Б. (2023) · Eurasian Journal of Academic Research · doi:10.70413/ejar-v03-i06-s4051
Цитокины как предикторы тяжести заболевания у пациентов с COVID-19
У., А. Т., Шамсутдинова, М. И., & Холбоева, Г. Б. (2023) · Eurasian Journal of Medical and Natural Sciences · doi:10.70413/ejmns-v03-i06-s9634
Coussement, G., Ilzkovitz, M., Baudelet, L., Meert, A., & Wolff, L. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.2009423
Supino, D., & Garlanda, C. (2026) · Zenodo (CERN European Organization for Nuclear Research) · doi:10.5281/zenodo.20122207
The networked landscape of cell death in sepsis: from dynamic pathway to node-targeted therapies
Zhu, X., Ya, P., Wang, H., Luo, X., Dong, Y., Maimaijuma, T., Xu, X., Liang, G., Huang, Z., Qi, L., et al. (2026) · Inflammation Research · doi:10.1007/s00011-026-02402-7
Investigating the Distribution: Signal, Noise, and the Resolution Toolkit in Evidence‐Based Medicine
Arthur, F. (2026) · Journal of Evaluation in Clinical Practice · doi:10.1111/jep.70551
Metadata
- Authors
- Shakoory, B., Carcillo, J. A., Chatham, W. W., Amdur, R. L., Zhao, H., Dinarello, C. A., Cron, R. Q., & Opal, S. M.
- Affiliations
- George Washington University (US)
- University of Pittsburgh Medical Center (US)
- University of Alabama at Birmingham (US)
- Temple University (US)
- University of Colorado Anschutz (US)
- Brown University (US)
- ORCID
- Venue
- Critical Care Medicine
- Published
- 2016-02
- Volume
- 44
- Issue
- 2
- Pages
- 275-281
- ISSN
- 0090-3493 (ISSN-L)
- PMC
- PMC5378312
- OpenAlex
- W2177407033
- Cited by
- 867
- References
- 48
- Citations by year
- 2026: 66 · 2025: 64 · 2024: 68 · 2023: 76 · 2022: 87 · 2021: 141 · 2020: 226 · 2019: 43 · 2018: 36 · 2017: 42 · 2016: 15
- FWCI
- 24.58
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Critical Care Medicine (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institute of General Medical Sciences (R01GM108618)
- Topics
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Sepsis Diagnosis and Treatment
- Health Sciences › Medicine › Hematology › Autoimmune and Inflammatory Disorders Research
- Life Sciences › Immunology and Microbiology › Immunology › Inflammation biomarkers and pathways
- Keywords
- sepsis, anakinra, interleukin-1 receptor antagonist, interleukin-1 blockade, 28-day mortality, hepatobiliary dysfunction, disseminated intravascular coagulation, multiple organ failure, septic shock, subgroup analysis, hyperferritinemia, cytokine storm
- MeSH terms
- Adolescent, Adult, Age Factors, Aged, Aged, 80 and over, Biliary Tract Diseases, Disseminated Intravascular Coagulation, Double-Blind Method, Female, Humans, Liver Diseases, Male, Middle Aged, Multiple Organ Failure, Respiratory Distress Syndrome, Sex Factors, Shock, Septic, Receptors, Interleukin-1, Sepsis, APACHE, Interleukin 1 Receptor Antagonist Protein, Macrophage Activation Syndrome, Young Adult, Acute Kidney Injury
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
